PubMed · 12801254
Practical model-based dose-finding in phase I clinical trials: methods based on toxicity.
Abstract
We describe two practical, outcome-adaptive statistical methods for dose-finding in phase I clinical trials. One is the continual reassessment method and the other is based on a logistic regression model. Both methods use Bayesian probability models as a basis for learning from the accruing data during the trial, choosing doses for successive patient cohorts, and selecting a maximum tolerable dose (MTD). These methods are illustrated and compared to the conventional 3+3 algorithm by application to a particular trial in renal cell carcinoma. We also compare their average behavior by computer simulation under each of several hypothetical dose-toxicity curves. The comparisons show that the Bayesian methods are much more reliable than the conventional algorithm for selecting an MTD, and that they have a low risk of treating patients at unacceptably toxic doses.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
P F Thall, S-J Lee. Practical model-based dose-finding in phase I clinical trials: methods based on toxicity.. https://doi.org/10.1046/j.1525-1438.2003.13202.x
Cite the original work for its findings. Save a collection to share your selection of sources.